Evidence map›Paper›PMID 35210797›Full record

ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2022

Adherence to Low-Carbohydrate Diets in Patients with Diabetes: A Narrative Review.

Nitya Kalyani Kumar, Jennifer D Merrill, Scott Carlson, Jashalynn German, William S Yancy

Open access · goldAbstract readReview
In one paragraph

Review in Diabetes, metabolic syndrome and obesity : targets and therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Low-carbohydrate diet for people with type 2 diabetes mellitus.The Cochrane database of systematic reviews · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Is Intermittent Fasting Better Than Continuous Energy Restriction for Adults with Overweight and Obesity?Diabetes, metabolic syndrome and obesity : targets and therapy · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Nitya Kalyani KumarDivision of Endocrinology, Diabetes, & Metabolism, Duke University, Durham, NC, USA.ORCID 0000-0002-7097-3313
Jennifer D MerrillDivision of Endocrinology, Diabetes, & Metabolism, Ohio State University, Columbus, OH, USA.
Scott CarlsonDivision of Endocrinology, Diabetes, & Metabolism, Duke University, Durham, NC, USA.
Jashalynn GermanDivision of Endocrinology, Diabetes, & Metabolism, Duke University, Durham, NC, USA.
William S YancyDuke Lifestyle and Weight Management Center and Division of General Medicine, Duke University, Durham, NC, USA.ORCID 0000-0003-1221-1860
Duke University · USThe Ohio State University · US

Funding

Endocrinology and Metabolism Training ProgramT32DK007012 · NIDDK · DUKE UNIVERSITY · PI DAVID A. D'ALESSIO · 1986 to 2026
$6.8M
NIDDK NIH HHS T32 DK007012
6 · The paper itself

Abstract

Evidence suggests that low carbohydrate (<130 g/day of carbohydrate) (LCD) and very low carbohydrate, ketogenic diets (typically <50 g/day of carbohydrate) (VLCKD) can be effective tools for managing diabetes given their beneficial effects on weight loss and glycemic control. VLCKD also result in favorable lipid profile changes. However, these beneficial effects can be limited by poor dietary adherence. Cultural, religious, and economic barriers pose unique challenges to achieving nutritional compliance with LCD and VLCKD. We review the various methods for assessing adherence in clinical studies and obstacles posed, as well as potential solutions to these challenges.

Indexed as

adherenceketogenic dietlow carbohydrate diettype 2 diabetes

Identifiers

PMID35210797
PMCPMC8863186
OpenAlexW4212956345

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.